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Flavones induce neutrophil apoptosis by down-
regulation of Mcl-1 via a proteasomal-
dependent pathway
Christopher D. Lucas,*,1 Keith C. Allen,* David A. Dorward,* Laura J. Hoodless,*
Lauren A. Melrose,* John A. Marwick,* Carl S. Tucker,† Christopher Haslett,*
Rodger Duffin,*,‡ and Adriano G. Rossi*
*Medical Research Council Centre for Inflammation Research and †British Heart Foundation Centre
for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh Medical
School, Edinburgh, UK; and ‡CXR Biosciences Ltd., Dundee Technopole, Dundee, UK
ABSTRACT Neutrophil apoptosis and subsequent
nonphlogistic clearance by surrounding phagocytes are
key to the successful resolution of neutrophilic inflam-
mation, with dysregulated apoptosis reported in multi-
ple human inflammatory diseases. Enhancing neutro-
phil apoptosis has proresolution and anti-inflammatory
effects in preclinical models of inflammation. Here we
investigate the ability of the flavones apigenin, luteolin,
and wogonin to induce neutrophil apoptosis in vitro and
resolve neutrophilic inflammation in vivo. Human neu-
trophil apoptosis was assessed morphologically and by
flow cytometry following incubation with apigenin, lu-
teolin, and wogonin. All three flavones induced time-
and concentration-dependent neutrophil apoptosis (apige-
nin, EC5012.2 M; luteolin, EC5014.6 M; and
wogonin, EC5028.9 M). Induction of apoptosis was
caspase dependent, as it was blocked by the broad-
spectrum caspase inhibitor Q-VD-OPh and was associ-
ated with both caspase-3 and caspase-9 activation. Fla-
vone-induced apoptosis was preceded by down-regulation of
the prosurvival protein Mcl-1, with proteasomal inhibi-
tion preventing flavone-induced Mcl-1 down-regulation
and apoptosis. The flavones abrogated the survival
effects of mediators that prolong neutrophil life span,
including lipoteichoic acid, peptidoglycan, dexametha-
sone, and granulocyte-macrophage colony stimulating
factor, by driving apoptosis. Furthermore, wogonin
enhanced resolution of established neutrophilic inflam-
mation in a zebrafish model of sterile tissue injury.
Wogonin-induced resolution was dependent on apopto-
sis in vivo as it was blocked by caspase inhibition. Our
data show that the flavones induce neutrophil apoptosis
and have potential as neutrophil apoptosis-inducing
anti-inflammatory, proresolution agents.—Lucas, C. D.,
Allen, K. C., Dorward, D. A., Hoodless, L. J., Melrose, L. A.,
Marwick, J. A., Tucker, C. S., Haslett, C., Duffin, R., Rossi,
A. G. Flavones induce neutrophil apoptosis by down-regula-
tion of Mcl-1 via a proteasomal-dependent pathway.
FASEB J. 27, 1084–1094 (2013). www.fasebj.org
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Neutrophils are key cells of the innate immune
system that are rapidly recruited to sites of infection or
tissue injury where they act to ensure host protection
against invading pathogens (1). This is achieved by
processes including neutrophil phagocytosis, degranu-
lation, and production of reactive oxygen species
(ROS) or by extruding strands of DNA coated with
antimicrobial peptides into the surrounding environ-
ment (NETosis). However, as these neutrophil func-
tions can lack specificity and can be injurious to host
tissues, it is important that neutrophil activity is tightly
regulated to prevent perpetuation of inflammation (2).
Despite having a life span of only hours under physio-
logical situations, neutrophil longevity is extended in
inflammatory environments by delaying apoptosis, a
form of programmed cell death. Nevertheless, once an
episode of acute neutrophilic inflammation is com-
plete, it is essential that neutrophil recruitment is
halted and that recruited neutrophils undergo apopto-
sis, before disposal of the apoptotic cells by surround-
ing phagocytes such as macrophages, to ensure effi-
cient resolution of inflammation (3). These processes
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allow fine control of neutrophil function, prevent neu-
trophil death by necrosis with consequent inflamma-
tion, and modulate macrophage phenotype toward
anti-inflammatory cytokine production (4, 5).
The natural resolution process of neutrophil apopto-
sis followed by phagocytosis is impaired in numerous
human inflammatory disease states, with delayed apo-
ptosis seen in conditions such as rheumatoid arthritis
(6) and acute respiratory distress syndrome (7) while
macrophage phagocytosis is defective in diseases such
as systemic lupus erythematosus (8) and asthma (9). It
is becoming increasingly clear that strategies that ma-
nipulate this physiological resolution process have both
anti-inflammatory and proresolution potential, with
agents that either enhance macrophage phagocytosis
or drive neutrophil apoptosis demonstrating utility in
preclinical models of both acute and chronic inflam-
mation. In particular, the induction of neutrophil apo-
ptosis by strategies such as cyclin-dependent kinase inhi-
bition (10–12), ligation of TNF-related apoptosis
inducing ligand (TRAIL; refs. 13, 14), lipid mediators
(15–17), antimicrobial agents (18), or modulators of
intracellular survival pathways (19) have all shown benefit
in preclinical models of neutrophilic inflammation.
Flavones are phenolic compounds from the class of
flavonoids present in a wide variety of plant material
and form a core component of many herbal medicines
(20). The health benefits of a diet high in plant
material have long been known, with flavone-rich foods
suggested to be protective against the development of
atherosclerosis and dementia, although the exact
mechanism of action remains unknown (21, 22). One
possibility relates to flavones acting as potential anti-
inflammatory compounds secondary to their antioxi-
dant properties (23) as well as inhibiting several proin-
flammatory signaling cascades and transcription factors
(24–27). Furthermore, anti-inflammatory and antitu-
mor effects of flavones have been demonstrated in vivo
due to their ability to influence cellular apoptosis.
However, the ability of flavones to influence proresolu-
tion pathways such as neutrophil apoptosis has not
previously been studied.
Here we demonstrate that the flavones apigenin,
luteolin, and wogonin drive primary human neutrophil
apoptosis in a caspase-dependent fashion even in the
presence of powerful neutrophil prosurvival factors. In
addition, we show that the flavones induce neutrophil
apoptosis by degradation of the key endogenous neu-
trophil survival protein myeloid cell leukemia-1 (Mcl-1)
in a proteasomal-dependent fashion. Furthermore, we
investigate the ability of wogonin to enhance resolution
of established neutrophilic inflammation in a zebrafish
model of sterile tissue injury.
MATERIALS AND METHODS
Neutrophil isolation and culture
Granulocytes were isolated from the peripheral blood of healthy
donors as described previously (11, 28, 29); ethics approval was
obtained from the Lothian Research Ethics Committee (ap-
proval no. 08/S1103/38). Neutrophil isolates were 96%
pure (with 1-3% contaminating eosinophils) as confirmed
by morphological appearance using light microscopy. Cells
were resuspended at 5  106/ml in Iscove’s modified
Dulbecco’s medium (PAA, Pasching, Austria) plus 5%
autologous serum and cultured at 37°C with 5% CO2 with
apigenin, luteolin, wogonin, lipoteichoic acid (from Staph-
ylococcus aureus), and peptidoglycan (from Staphylococcus
aureus) (all from Sigma, Dorset, UK); and Q-VD-OPh,
dexamethasone, and granulocyte-macrophage colony-stim-
ulating factor (GM-CSF) (all from R&D, Abingdon, UK),
alone or in combination.
Assessment of viability and apoptosis
Viability, apoptosis, and necrosis were assessed by flow cytometry
using annexin-V-conjugated fluorescein isothiocynate (FITC;
Roche, Welwyn Garden City, UK) and propidium iodide (PI;
Sigma) as described previously (10, 28). Briefly, annexin-V was
diluted 1:500 in binding buffer (HBSS with 2.5 mM Ca2) and
280 l was added to 20 l of cells. After 10 min of incubation at
4°C, 1 l of PI (1 mg/ml) was added to each sample before
immediate analysis on a FACScan flow cytometer (BD, Oxford,
UK). Neutrophil apoptosis was confirmed by cyto-centrifugation
of 80l of sample at 300 rpm for 3min. Samples were then fixed
with methanol and stained with Diff-Quick (Gamidor, Didcot,
UK) before morphological analysis (30).
Assessment of neutrophil activation
Shape change, CD11b up-regulation, and CD62L shedding
were assessed as described previously (28). Neutrophils were
resuspended in HBSS with cations and incubated with or
without the flavones (all at 50 M) on a shaking heat block
for 30 min before addition of N-formyl-Met-Leu-Phe (fMLP;
10 nM; Sigma) or control medium for a further 15 min.
Neutrophils were then incubated with appropriate antibodies
(CD11b, Biolegend, Cambridge, UK; CD62L, BD Pharmin-
gen) and analyzed by flow cytometry.
ROS generation was assessed by dihydrorhodamine (DHR)
fluorescence as described previously (28). Neutrophils resus-
pended in HBSS with cations were loaded with DHR (2 M;
Invitrogen, Carlsbad, CA, USA) for 10 min and then incu-
bated with or without the flavones (all at 50 M) or the
protein kinase C inhibitor Ro 31-8220 (1 M; Calibochem,
San Diego, CA, USA) on a shaking heat block for 30 min
before stimulation with phorbol 12-myristate 13-acetate
(PMA; 300 nM; Sigma) or control for a further 15 min, and
DHR fluorescence was analyzed by flow cytometry (FL-1).
Intracellular calcium was analyzed by spectrofluorimetry of
fura-2 (2 M; Sigma) labeled neutrophils as described previ-
ously (31) in response to addition of the flavones (all at 50
M) or the formyl peptide receptor 1 antagonist cyclosporine
H (Enzo Lifesciences, Exeter, UK) and subsequently by fMLP
(10 nM) and platelet-activating factor (PAF; 10 nM; Sigma).
Western blotting
Following incubation with compounds as per figure legends,
neutrophils (5106/ml) were lysed for 10 min with 0.1%
Nonidet P40 in Tris-buffered saline (TBS) containing a
protease inhibitor cocktail as described previously (32). Fol-
lowing BCA protein assay (Thermo Scientific, Cramlington,
UK) to ensure equal protein loading, lysates were run on a
12% SDS gel (Thermo Fisher Scientific) and transferred onto
polyvinylidene difluoride (PVDF) membranes (Millipore,
Bedford, MA, USA). Membranes were blocked with 5% dried
milk (Marvel, Knighton, UK) in TBS/0.1% Tween-20 before
incubation with antibodies against Mcl-1 (1:500; Santa-Cruz,
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Santa Cruz, Biotechnology, CA, USA), GAPDH (1:10,000;
Sigma), cleaved caspase-3 (1:1000, Cell Signaling, Danvers,
MA, USA), and cleaved caspase-9 (1:1000; Cell Signaling).
After 3 washes with TBS/0.1% Tween-20, membranes were
incubated with the appropriate horseradish-peroxidase-con-
jugated secondary antibodies (1:2500; Dako Cambridgeshire,
UK). Finally, blots were incubated with ECL prime (GE
Healthcare, Little Chalfont, UK), exposed to light-sensitive
film (Kodak, Rochester, NY, USA) and processed through an
X-ray developer (Xograph Imaging Systems, Tetbury, UK).
In vivo sterile tissue injury
Transgenic zebrafish [Tg(mpx:eGFPi114); ref. 33; a kind gift
from Dr. Steve Renshaw, University of Sheffield, Sheffield, UK],
which have fluorescently labeled neutrophils, were maintained
according to standard protocols. Three day postfertilization
larvae were anesthetized in tricaine and the tail fin transected by
a sterile scalpel (34). Individual fish were then imaged using a
fluorescent microscope (8 view), and neutrophil numbers at
the site of tissue injury were counted at 0, 4, and 24 h post-tail
median fin transection. Zebrafish were exposed to flavones or
DMSO controls as per figure legends from 4 h post-tail fin
transection onward with stock solutions diluted in embryo
medium (35) such that the final concentration of DMSO never
exceeded 0.2%. For the experiments with the caspase inhibitor
zVAD-FMK (zVAD; Tocris Bioscience, Bristol, UK), 2 nl of 100
mM zVAD (or DMSO control) was microinjected into the yolk
sac 3.5 h after tail fin transaction, and zebrafish were exposed to
wogonin from 4 h onward.
Data handling and statistical analysis
All flow cytometry data were analyzed using FlowJo software
(Treestar, Ashland, OR, USA). Analysis of zebrafish images
was carried out using ImageJ software (U.S. National Insti-
tutes of Health, Bethesda, MD, USA). All neutrophil experi-
ments were conducted in duplicate using cells isolated from
3 different donors per experiment, and results are ex-
pressed as means  se. Data were analyzed by 1-way ANOVA
with a Newman-Keuls multiple comparison post hoc test, or by
a 2-tailed unpaired t test for zebrafish experiments (Prism 5;
GraphPad, San Diego, CA, USA), with significance accepted
at values of P  0.05.
RESULTS
Flavones apigenin, luteolin, and wogonin drive
primary human neutrophil apoptosis in a time- and
concentration-dependent manner
To investigate the ability of the flavones to induce apo-
ptosis, primary human neutrophils were incubated with
increasing concentrations of apigenin, luteolin, and
wogonin (chemical structures given in Fig. 1A–C) for 4–6
h before viability and apoptosis assessment by flow cytom-
etry and morphological examination. All three flavones
resulted in a time- and concentration-dependent decrease
in neutrophil viability (Fig. 1D–F) secondary to the induc-
tion of neutrophil apoptosis (Fig. 1G–I). After 6 h of
flavone treatment at concentrations50 M, there was a
marked increase in annexin V positive cells (Fig. 1J–M).
Similarly, cellular morphology revealed the appearance of
cells with characteristic changes of apoptosis (such as
nuclear condensation and cellular shrinkage) in flavone-
treated groups. EC50 calculation revealed values of 12.2
M for apigenin, 14.6 M for luteolin, and 28.9 M for
wogonin at 6 h.
To investigate the effect of flavones on other neutro-
phil functions, we measured shape change, CD11b
up-regulation, CD62L shedding, ROS generation, and
intracellular calcium flux both in response to treatment
with the flavones as well as with subsequent stimulation
with neutrophil agonists (Supplemental Fig. S1). The
flavones did not induce shape change or inhibit fMLP-
induced shape change (Supplemental Fig. S1A–C).
Although the flavones did not themselves induce
changes in CD11b, the subsequent response to fMLP-
induced CD11b was unchanged with apigenin (Supple-
mental Fig. S1D), reduced with luteolin (Supplemental
Fig. S1E), and increased with wogonin (Supplemental
Fig. S1F). Luteolin and wogonin both caused partial
down-regulation of CD62L; however, fMLP-induced
CD62L shedding was unchanged by pretreatment with
the flavones (Supplemental Fig. S1G–I). PMA-induced
ROS production was attenuated by all three flavones,
consistent with their known role as antioxidants; however,
the flavones by themselves did not induce ROS genera-
tion (Supplemental Fig. S1J–K). The protein kinase C
inhibitor Ro 31-8220 (Ro) was included as a positive
control, as ROS generation is known to be regulated by
protein kinase C. Transient increases in intracellular
calcium are essential for multiple neutrophil functions.
The flavones did not cause a rise in intracellular calcium,
with flavone-treated neutrophils still able to increase
intracellular calcium in response to fMLP and PAF (Sup-
plemental Fig. S1L). In contrast, the formyl peptide
receptor 1 antagonist cyclosporine H markedly inhibited
the intracellular calcium rise in response to fMLP.
Flavones induce caspase-dependent apoptosis in
primary human neutrophils
Caspase enzymes play a critical role in the process of
apoptosis. To investigate whether the caspase pathway
was involved in flavone-induced neutrophil apoptosis, a
highly effective pharmacological pan caspase inhibitor
(QVD-OPh) was used. Flavone-induced apoptosis was
dependent on caspase enzyme activation, as coincuba-
tion of neutrophils with Q-VD-OPh abolished the ability
of the flavones to induce apoptosis at both 6 and 20 h
of incubation (Fig. 2). Coincubation of flavones and
Q-VD-OPh also prevented progression of neutrophils
into secondary necrosis which was evident at the 20h
time point (Fig. 2B). The temporal distribution of the
necrosis, with apoptosis occurring before the onset of
necrosis, as well as the observation that the necrosis can
be abrogated by inhibition of apoptosis, confirms this
as secondary necrosis. Furthermore, Q-VD-OPh also
prevented constitutive neutrophil apoptosis, consistent
with published literature (Fig. 2B and ref. 36).
Flavones induce apoptosis of neutrophils by
down-regulation of Mcl-1 via a proteasomal-dependent
pathway
To further investigate the molecular mechanisms be-
hind the flavones’ ability to induce neutrophil apopto-
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sis, Western blotting was carried out to determine levels
of the key neutrophil intracellular survival protein
Mcl-1 after 4 h of culture. The flavones apigenin and
luteolin (both at 50 M) caused significant down-
regulation of Mcl-1 at the protein level (Fig. 3A).
Although wogonin appeared to have only a small effect
on Mcl-1 levels at 50 M at this time point, a higher
concentration of wogonin (100 M) caused marked
Mcl-1 down-regulation at 4 h (Fig. 3B). This is consis-
tent with the relatively reduced potency of wogonin
Figure 1. Flavones apigenin, luteolin,
and wogonin induce human neutro-
phil apoptosis in a time- and concen-
tration-dependent manner. A–C) Chem-
ical structures of the flavones apigenin
(A), luteolin (B), and wogonin (C).
Neutrophils were cultured for 4 or 6 h
in increasing concentrations of the
flavones apigenin, luteolin, and wogonin
before neutrophil viability, apoptosis
and necrosis determination by flow
cytometric analysis of annexin-V (AnnV)/
PI binding. D–F) A time- and concen-
tration-dependent reduction in neu-
trophil viability is seen with apigenin
(D), luteolin (E), and wogonin (F); n 
4. G–I) Reduction in neutrophil viabil-
ity is secondary to induction of neutro-
phil apoptosis with concentration re-
sponse curves at 6 h of culture shown for apigenin (G), luteolin (H), and wogonin (I); n  4. J–M) Representative flow
cytometry plots of annexin-V (AnnV; x axis)/PI (y axis) binding and representative cyto-centrifuge preparations after
staining with Diff-Quick are shown at 6 h for control (J), 50 M apigenin (K), 50 M luteolin (L), and 50 M wogonin (M).
Cyto-centrifuge preparations (1000 view) demonstrate increased numbers of neutrophils with apoptotic morphology in
the flavone-treated group. Data are expressed as means  se, analyzed by ANOVA with a Newman-Keuls multiple
comparison test. *P  0.05, ***P  0.001 vs. control.
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compared with the other two flavones. To investigate
the mechanism behind the flavone-induced down-reg-
ulation of Mcl-1, neutrophils were cultured with the
flavones apigenin, luteolin, and wogonin (all at 50 M)
with and without the proteasomal inhibitor bortezomib
(at 10 M) (37) for 4 h before Western blotting for
Mcl-1. Proteasomal inhibition reduced the loss of Mcl-1
in flavone-treated neutrophils as well as reduced Mcl-1
loss in neutrophils undergoing constitutive apoptosis
(control vs. bortezomib-treated neutrophils; Fig. 3C).
Proteasomal inhibition, by reducing flavone-induced
Mcl-1 down-regulation, also prevented flavone-induced
neutrophil apoptosis as determined by flow cytometry
and neutrophil morphology (Fig. 3D–I). The effects of
proteasomal inhibition by bortezomib were concentra-
tion dependent, with a higher concentration of bort-
ezomib (50 M) reducing flavone-induced apoptosis
back toward control levels (Fig. 3J). To further investi-
gate the temporal association between flavone-induced
Mcl-1 down-regulation and caspase activation, Western
blotting was carried out at 2, 4, and 6 h in both control
and wogonin-treated (50 M) neutrophils (Fig. 3K).
Mcl-1 down-regulation was evident by 4 h of culture,
with accelerated caspase-3 cleavage in wogonin-treated
cells from this time onward. In addition, wogonin
caused early and accelerated caspase-9 cleavage, consis-
tent with apoptosis induction via the intrinsic pathway
of apoptosis (Fig. 3K). Furthermore, all 3 flavones
enhanced loss of mitochondrial outer membrane po-
tential in neutrophils (data not shown), a key event in
the intrinsic pathway of apoptosis.
Prosurvival effects of multiple inflammatory
mediators on neutrophil life span can be overridden
by flavones
Neutrophils are exposed to inflammatory mediators at
sites of inflammation that extend their life span by
delaying apoptosis. As the flavones were able to induce
apoptosis in unstimulated human neutrophils, we in-
vestigated the ability of flavones to counteract the
prosurvival effects of multiple inflammatory mediators.
The bacterial cell wall components peptidoglycan and
lipoteichoic acid, the synthetic glucocorticoid dexa-
methasone, and GM-CSF all extended neutrophil life
span at 20 h of culture (Fig. 4). The flavones apigenin,
luteolin, and wogonin were able to override the anti-
apoptotic, prosurvival effect of all four mediators stud-
ied by inducing neutrophil apoptosis (Fig. 4).
Wogonin enhances resolution of sterile neutrophilic
inflammation
Having demonstrated that the flavones were able to
induce neutrophil apoptosis in vitro, we examined the
ability of flavones to enhance resolution in established
neutrophilic inflammation using a zebrafish model of
sterile tissue injury. Initial experiments suggested that
wogonin had the most potent effect in our in vivo
zebrafish model (data not shown), and this was there-
fore used as the lead compound for all in vivo experi-
ments. By use of transgenic zebrafish [Tg(mpx:eGFP)],
which have fluorescently labeled neutrophils, neutro-
phil presence at the site of injury can be serially imaged
in a single organism. Following sterile transection of
the tail fin, neutrophils are observed at the site of injury
within 1 h (data not shown) with peak neutrophil
numbers observed at around 4 h postinjury (Fig. 5B).
By 24 h postinjury, spontaneous resolution of the
neutrophilic inflammation begins with reductions in
neutrophil numbers observed (Fig. 5A, B and ref. 34).
Addition of wogonin (50 M) at the peak of inflamma-
tion (4 h post-tail fin transection) was able to enhance
resolution of established neutrophilic inflammation as
assessed by cellular infiltration to the site of injury (Fig.
5). The percentage reduction in neutrophils from peak
of inflammation to the 24 h time point in each individ-
ual fish is also shown (Fig. 5C). This gave a resolution
interval (Ri; the time taken for neutrophil numbers at
the site of inflammation to decline to half maximal (38,
39) for wogonin of 23 h, whereas the Ri for control
zebrafish was 48 h (data not shown). To assess
whether wogonin was causing enhanced resolution of
neutrophilic inflammation by induction of apoptosis in
vivo, separate zebrafish were microinjected with the
caspase inhibitor zVAD to inhibit apoptosis. Treatment
with zVAD attenuated the ability of wogonin to reduce
the neutrophilic inflammation, confirming wogonin-
Figure 2. Flavones induce caspase-dependent apoptosis in primary human neutrophils. A, B) Neutrophils were cultured with the
flavones apigenin, luteolin, and wogonin (all at 50 M) with and without the broad spectrum caspase inhibitor Q-VD-OPh
(Q-VD; 10 M) before neutrophil viability, apoptosis, and necrosis assessment by flow cytometric analysis of annexin-V/PI
binding at both 6 h (A) and 20 h (B); n  3. The presence of Q-VD-OPh dramatically inhibited the ability of flavones to induce
apoptosis. C, D) Representative flow cytometry plots of annexin-V (x axis)/PI (y axis) binding are shown at 6 h for 50 M
apigenin (C) and 50 M apigenin plus 10 M Q-VD-OPh (D). Data are expressed as means  se, analyzed by ANOVA with a
Newman-Keuls multiple comparison test. ***P  0.001 vs. Q-VD-OPh-treated sample.
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induced caspase-dependent apoptosis was occurring in
vivo (Fig. 5D).
DISCUSSION
Neutrophils are central to host immunity, with a key
role in the defense against invading bacteria, fungi,
and viruses. Their normally short life span in the
circulation can be manipulated and extended at sites
of inflammation to ensure an appropriate host re-
sponse is mounted in response to infection or tissue
injury. However, uncontrolled neutrophil recruit-
ment or inappropriate neutrophil longevity is patho-
physiologically involved in inflammatory diseases
with unresolved neutrophilic inflammation and low
levels of neutrophil apoptosis seen in multiple hu-
man inflammatory disease states. Pharmacological
manipulation of such defective resolution pathways is
therefore an attractive avenue for the development
of novel proresolution anti-inflammatory treatments
(40). Modulation of granulocyte apoptosis either by
inhibition of kinases, by ligation of death receptors,
or by use of lipid mediators have demonstrated
efficacy in multiple preclinical models of inflamma-
tory disease (10, 11, 13, 15). Furthermore, the effi-
cacy of glucocorticosteroids in the treatment of in-
flammatory diseases such as asthma is thought to be
linked to their ability to enhance eosinophil apopto-
sis, with increased eosinophil apoptosis seen in
asthma following commencement of steroid treat-
Figure 3. Flavones induce apoptosis of
neutrophils by down-regulation of Mcl-1
via a proteasomal dependent pathway.
A) Neutrophils were cultured for 4 h
in either control medium or 50 M of
the flavones apigenin, luteolin, and
wogonin before Western blotting for
Mcl-1 (40 kDa) and GAPDH (37 kDa).
B) Neutrophils were cultured for 4 h in
either control medium, 10 or 100 M of
the flavone wogonin before Western
blotting for Mcl-1 and GAPDH. C) To
investigate whether Mcl-1 down-regu-
lation was dependent on proteasomal degradation of Mcl-1, neutrophils were cultured with the flavones apigenin, luteolin,
and wogonin (all at 50 M) with and without the proteasomal inhibitor bortezomib (Bortez; 10 M) for 4 h before Western
blotting for Mcl-1 and GAPDH. D–I) Proteasomal inhibition attenuated down-regulation ofMcl-1 as well as attenuated the ability
of the flavones to induce apoptosis, with representative flow cytometry plots of annexin-V (x axis)/PI (y axis) binding and
representative cyto-centrifuge preparations after staining with Diff-Quick shown for apigenin (50 M) alone (D), apigenin plus
bortezomib (Bortez; 10 M; E), luteolin (50 M) alone (F), luteolin plus bortezomib (G), wogonin (50 M) alone (H), and
wogonin plus bortezomib (I), all at 6 h. J) Cumulative apoptosis data for n 	 4 experiments. K) To further investigate
flavone-induced down-regulation of Mcl-1 and activation of caspases, neutrophils were cultured for 2, 4, or 6 h in either
control medium or wogonin (50 M) before lysis and Western blotting for Mcl-1, cleaved caspase-3 (17/19 kDa), cleaved
caspase-9 (35/37 kDa), and GAPDH. All Western blots representative of n  3 separate experiments. Data are expressed
as means  se, analyzed by ANOVA with a Newman-Keuls multiple comparison test. **P  0.01, ***P  0.001 vs. control;
#P  0.05, ##P  0.01 vs. flavone-treated sample.
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ment (41). This is in contrast to use of glucocortico-
steroids in neutrophilic inflammation where their
relative lack of efficacy may be linked to their ability
to inhibit neutrophil apoptosis (42).
Here we have shown that polyphenolic plant-derived
compounds, the flavones, induce primary neutrophil
apoptosis in vitro. Apigenin (derived from parsley),
luteolin (present in a wide variety of leaves as well as
celery and peppers), and wogonin (derived from Scute-
llaria and an active ingredient in the Japanese herbal
supplement sho-saiko-to) were all able to drive neutro-
phil apoptosis in a time- and concentration-dependent
fashion. Furthermore, the flavones were able to over-
ride multiple powerful prosurvival mediators, including
bacterial constituents [e.g., lipoteichoic acid (LTA) and
peptidoglycan] and host-derived factors (e.g., GM-CSF),
frequently found at increased concentration at sites of
inflammation where they act to delay neutrophil apo-
ptosis. This ability of flavones to override survival
factors and drive apoptosis is important to ensure that
such neutrophil apoptosis-inducing effects are not lost
at sites of inflammation in vivo. An apoptosis-inducing
effect of flavones on neutrophils is in contrast to their
studied effects on cardiomyocytes, neurones, and lym-
phocytes, where inhibition of apoptosis is observed
(43–45). It is not entirely clear why the effect of
flavones on apoptosis varies between cell types; how-
ever, recent evidence has suggested that flavones pre-
vent cardiomyocyte apoptosis by inhibiting glycogen
synthase kinase-3 (GSK-3) induced p53 translocation
in this cell type (46). By comparison, polyphenolic
compounds, including flavones, have been demon-
strated to exert a proapoptotic effect on malignant cells
both in vitro and in vivo (47–49). However, it is clear
that pharmacological induction of apoptosis is a highly
cell type specific event with dexamethasone delaying
neutrophil apoptosis but inducing rapid apoptosis in
the closely related eosinophil.
Apoptosis can proceed via either an extrinsic path-
way on ligation of a death receptor (including TNF-
,
Fas, and TRAIL) or an intrinsic pathway in response to
cellular stress (withdrawal of survival factors, ischemia,
etc.), chemotherapeutic agents, or ultraviolet damage.
The intrinsic pathway is controlled by the balance of
pro- vs. antiapoptotic proteins from the B-cell lym-
phoma 2 (Bcl-2) family, which together regulate mito-
chondrial outer membrane permeabilization and re-
lease of proapoptotic substances (such as cytochrome
c) from mitochondria (40). Both pathways eventually
act through activation of enzymes called caspases (cys-
teine aspartic specific proteases), which are responsible
for the numerous morphological and biochemical
changes of apoptosis. Flavone-induced neutrophil apo-
ptosis was critically dependent on activity of caspase
enzymes, as apoptosis was completely blocked in vitro by
use of the broad-spectrum caspase inhibitor Q-VD-OPh.
Consistent with this dependence on activated caspases
for the action of flavones, we observed that wogonin
caused accelerated activation of caspase-3 which was
evident by 4 h, before the induction of apoptosis, which
was observable by 6 h. Furthermore, the proresolution
effect of wogonin in vivo was dependent on activation
Figure 4. Prosurvival effects of multiple inflammatory mediators on neutrophil life span can be overridden by flavones.
Neutrophils were cultured in the presence of the neutrophil prosurvival factors peptidoglycan (PepG; 10 g/ml), LTA (30
g/ml), dexamethasone (Dex; 100 nM), or granulocyte-macrophage colony-stimulating factor (GM-CSF; 20 ng/ml) with and
without the flavones apigenin, luteolin and wogonin (all at 100M) before flow cytometric analysis of annexin-V/PI binding.
A–D) Neutrophil viability after 20 h for peptidoglycan (A), LTA (B), dexamethasone (C), and GM-CSF (D); n 	 3–4. D–I)
Representative flow cytometry plots of annexin-V (x axis)/PI (y axis) binding for control (E), GM-CSF alone (20 ng/ml; F),
GM-CSF and apigenin (G), GM-CSF and luteolin (H), and GM-CSF and wogonin (I) at 6 h of culture. Data are expressed as
means  se, analyzed by ANOVA with a Newman-Keuls multiple comparison test. *P  0.05, **P  0.01, ***P  0.001 vs.
prosurvival factor alone; #P  0.05, ###P  0.001 vs. control.
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of caspases as it was inhibited by the broad-spectrum
caspase inhibitor zVAD (Fig. 5D).
Both extrinsic and intrinsic pathways of apoptosis can
affect neutrophil life span, with TRAIL and Fas ligation
causing neutrophil apoptosis while TNF-
 causes early
apoptosis but late neutrophil survival dependent on
NF-B activation (32, 50). Cytokine-mediated neutro-
phil survival occurs secondary to Bcl-2 member altera-
tions such as Bax down-regulation (a proapoptotic
member; refs. 51, 52) while pharmacological induction
of neutrophil apoptosis by cyclin-dependent kinase
inhibitors or sodium salicylayte can do so by down-
regulating prosurvival Bcl-2 members (28, 53). Neutro-
phils lack the main Bcl-2 antiapoptotic homologue
Bcl-2 itself and instead have increased dependence on
the antiapoptotic Mcl-1. Mcl-1 is an unusual Bcl-2
member, as it has a very short half-life of only a few
hours, secondary to PEST domains [proline (P), glu-
tamic acid (E), serine (S), threonine (T)] and consti-
tutive ubiquitination, which target the protein for pro-
teasomal degredation. The importance of Mcl-1 in
regulating neutrophil survival is revealed by myeloid
specific deletion of Mcl-1 in mice, which leads to
neutropaenia without any observable defects in macro-
phage number or function (54). Furthermore, Mcl-1
levels can be influenced by neutrophil prosurvival
factors, with GM-CSF, hypoxia, and cAMP cyclic aden-
osine monophosphate (cAMP) all promoting neutro-
phil longevity with enhanced Mcl-1 levels (55–58).
Flavone-induced neutrophil apoptosis occurs following
down-regulation of Mcl-1, with levels of Mcl-1 falling
before induction of apoptosis suggesting that the fla-
vone-induced decrease in Mcl-1 is a key and early event
in the induction of neutrophil apoptosis. Flavone-
induced down-regulation was dependent on activity of
the proteasome as use of the proteasomal inhibitor
bortezomib (37) increased Mcl-1 levels in flavone-
treated neutrophils. Furthermore, enhanced levels of
Mcl-1 secondary to proteasome inhibition prevented
both constitutive and flavone-induced neutrophil apo-
ptosis, confirming the key role of Mcl-1 levels in gov-
erning the onset of neutrophil apoptosis. Whether
flavones enhance Mcl-1 targeting for proteasomal deg-
redation or increase the general activity of the protea-
some remains to be investigated. Such alterations in
Mcl-1 levels following flavone treatment, accelerated
appearance of cleaved caspase-9, and enhanced loss of
neutrophil mitochondrial outer membrane potential
(data not shown) together confirm that flavones act via
the intrinsic pathway of apoptosis in neutrophils.
Anti-inflammatory properties of flavones have been
suggested for some time, with a high dietary intake in
humans associated with a reduced incidence of inflam-
matory diseases, such as atherosclerosis (21). The pro-
Figure 5. The flavone wogonin enhances resolution of sterile neutrophilic inflammation. At 3 d postfertilization, transgenic
zebrafish [Tg(mpx:eGFPi114)], which have fluorescently labeled (eGFP) neutrophils, underwent tailfin transection to induce
sterile tissue injury. Individual fish were then serially imaged at 0, 4, and 24 h postinjury with quantification of neutrophil
numbers at the site of injury with wogonin (50 M) or vehicle control added at 4 h postinjury. A) Representative images ( 8
view) taken by fluorescent microscope with a GFP filter at 0 h (i), 4 h (ii), 24 h control (iii), and 24 h wogonin-treated (iv). B)
Cumulative data (n23, 5 separate experiments). C) Percentage reduction in neutrophil numbers between 4 and 24 h for each
fish. D) To assess the role of apoptosis in the wogonin-treated fish, zebrafish were microinjected with the caspase inhibitor zVAD
at 3.5 h postinjury, with addition of wogonin to the medium at 4 h postinjury. Neutrophil numbers were imaged at 4 and 24 h;
percentage reduction in neutrophil numbers between these time points is shown (n6, 2 separate experiments). Data are
expressed as means  se, analyzed by a 2-tailed unpaired t test (B, C) or by ANOVA with a Newman-Keuls multiple comparison
test (D). **P  0.01 vs. control (B, C) or wogonin (D).
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posed mechanism behind such anti-inflammatory prop-
erties of flavones in humans centers around their ability
to act as antioxidant agents (Supplemental Fig. S1 and
ref. 23). While their antioxidant abilities may play a role
in the protection against atheroma, such antioxidant
activity is unlikely to be the mechanism behind flavone-
induced neutrophil apoptosis, especially considering
that the flavones by themselves did not induce changes
in neutrophil ROS generation. Furthermore, antioxi-
dant molecules traditionally cause enhanced neutro-
phil life span by delaying neutrophil apoptosis (59, 60),
while production of neutrophil ROS is associated with
the induction of neutrophil apoptosis in a variety of
experimental situations (61).
Preclinical investigation of flavones have also re-
vealed anti-inflammatory properties with luteolin atten-
uating endotoxin-mediated lung injury and bleomycin-
induced lung fibrosis in mice (62–64), concomitant
baicalin (a flavone) and antibiotics showing beneficial
effects in experimental meningitis (65), and baicalin
alone improving survival in a mouse model of polymi-
crobial sepsis secondary to caecal ligation and puncture
(45). In these studies, the suggested mechanism behind
the anti-inflammatory effects of flavones have varied
from inhibition of intracellular signaling cascades
[such as mitogen-activated protein kinase (MAPK) and
phosphoinositide-3-kinase (PI3K)], to reduced cyto-
kine production (such as TNF-
 and IL-1), to enhanced
clearance of bacteria, and to inhibition of lymphocyte
apoptosis. In several of these studies, reduced levels of
neutrophils in inflammatory exudates have been ob-
served (45, 63, 64, 66), but to our knowledge our study
is the first to characterize the direct effects of flavones
on the regulation of neutrophil life span. Furthermore,
we have demonstrated the utility of such neutrophil-
apoptosis inducing effects in vivo, by using wogonin to
enhance the resolution of established neutrophilic
inflammation following sterile tissue injury. Our initial
in vivo experiments in the zebrafish suggested wogonin
had the most potent proresolution effects (data not
shown), despite having the highest EC50 of all three
compounds tested. This may in part relate to the poor
water solubility of the flavone compounds, a factor of
vital importance in the aqueous environment of the
zebrafish. This issue of drug solubility and poor absorp-
tion in the zebrafish has been reported by others (67)
and was also demonstrated with use of the broad
spectrum caspase inhibitor zVAD, which we found was
only effective following microinjection (Fig. 5 and data
not shown). Our studies have clearly shown a role for
apoptosis in the wogonin-induced resolution of ze-
brafish inflammation and like the mammalian system it
has recently become evident that proresolution pro-
cesses in the zebrafish also involve switching from
proinflammatory lipid synthesis to the active genera-
tion of anti-inflammatory and proresolution lipids (68).
Thus, we believe that careful future lipidomic analysis
of proinflammatory, anti-inflammatory, and proresolu-
tion lipid profiles in the zebrafish in response to
flavone treatment is warranted to better understand
inflammation resolution in our model.
Although apigenin has previously been reported to
be potentially proinflammatory in a rat model of intra-
pleural carrageenan-induced inflammation due to an
increase in total number of inflammatory cells (19),
differential inflammatory cell counts were not given
and total exudate volume was unchanged with apigenin
administration. In this experimental setup, it would be
key to know whether apigenin administration had effects
on the relative numbers of neutrophils in the exudate
fluid, especially as others have reported anti-inflammatory
effects of apigenin in rodents in other experimental
models (69). Alternatively, it may well be possible that
apigenin may exert differential effects when administered
at different phases of the inflammatory response or that
effects may be inflammatory stimulus specific.
Although any potential neutrophil apoptosis-induc-
ing proresolution therapy needs to be balanced with
the absolute requirement of functioning neutrophils
for protection against invading pathogens, preclincal
experiments have not revealed any impaired ability to
control nonsterile inflammation. For example, induc-
tion of neutrophil apoptosis along with antimicrobial
therapy in a model of bacterial meningitis leads to both
reduced inflammation and enhanced recovery from
infection (12), while proresolving lipid mediators such
as resolvin E1 reduce neutrophil number while also
enhancing bacterial clearance in a rodent model of
pneumonia (17). Conversly, delaying neutrophil apo-
ptosis by deletion of the proapoptotic Bcl-2 family
member p53 upregulated modulator of apoptosis
(PUMA) leads to enhanced inflammation and an in-
ability to control bacterial infection (70). These find-
ings may in part be explained by stimulated, inflamma-
tory neutrophils having altered sensitivity toward
apoptosis-inducing stimuli. For example, TRAIL-defi-
cient mice show normal circulating neutrophil num-
bers and normal constitutive neutrophil apoptosis but
demonstrate impaired apoptosis when exposed to an
inflammatory environment (13), while the cyclin-de-
pendent kinase inhibitor induced down-regulation of
Mcl-1 is accelerated in the presence of GM-CSF (10).
Such findings suggest that neutrophil apoptosis-induc-
ing strategies such as flavones may allow ongoing
antimicrobial clearance while targeting excessive in-
flammation even in nonsterile human inflammatory
diseases.
In summary, we have demonstrated that flavones
drive neutrophil apoptosis in a caspase-dependent
fashion to override survival factor-induced delay of
apoptosis by down-regulating the key neutrophil
survival protein Mcl-1 in a proteasomal-dependent
fashion. Enhanced resolution of inflammation is
seen following addition of wogonin to already estab-
lished neutrophilic inflammation in vivo. As such,
flavones may be a novel class of neutrophil apoptosis-
inducing anti-inflammatory compounds for the treat-
ment of human inflammatory disease.
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